Cargando…

Identification of a novel immune checkpoint regulator and potential therapeutic antibody target in oncology

Detalles Bibliográficos
Autores principales:	Sallee, Nathan, Karasyov, Artur, Bellovin, David, Liang, Ryan, de la Torre, Jacqueline, Palencia, Servando, Lee, Ernestine, Hestir, Kevin, Brennan, Thomas, Borges, Luis, Brace, Arthur, Wong, Brian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4649422/ http://dx.doi.org/10.1186/2051-1426-3-S2-P195

Ejemplares similares

Identification of novel immune regulators of tumor growth using RIPPS screening in vivo
por: Brennan, Tom, et al.
Publicado: (2015)

Discovery of novel immune checkpoint regulators in a comprehensive library of human extracellular proteins
por: Sallee, Nathan A, et al.
Publicado: (2014)

cmFPA008, an anti-mouse CSF-1R antibody, combines with multiple immunotherapies to reduce tumor growth in nonclinical models
por: Bellovin, David, et al.
Publicado: (2015)

Preclinical characterization of bemarituzumab, an anti-FGFR2b antibody for the treatment of cancer
por: Xiang, Hong, et al.
Publicado: (2021)

Development of novel oncology biomarkers for cancer
por: Yoganathan, Nathan
Publicado: (2014)

Targeting of phosphatidylserine by monoclonal antibodies enhances activity of immune checkpoint inhibitors in breast tumors
por: Gong, Jian, et al.
Publicado: (2014)

Direct comparisons of T cell costimulation and checkpoint blockade in the setting of tumor-targeted monoclonal antibody therapy
por: Khalil, Danny, et al.
Publicado: (2015)

Immune Checkpoint Inhibitors: The Unexplored Landscape of Geriatric Oncology
por: Choucair, Khalil, et al.
Publicado: (2022)

Targeting of phosphatidylserine by monoclonal antibodies reverses an immunosuppressive checkpoint inducing innate and specific anti-tumor responses
por: Gong, Jian, et al.
Publicado: (2013)

Digital mammography: the human factors implications
por: Brace, C, et al.
Publicado: (2006)

The Glycosylation of Immune Checkpoints and Their Applications in Oncology
por: Zheng, Linlin, et al.
Publicado: (2022)

Heterogeneity in myocardial iron content in pediatric and young adult patients
por: Slesnick, Tim, et al.
Publicado: (2013)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Levy, Ofer, et al.
Publicado: (2014)

Monoclonal antibody therapies targeting immune checkpoints induce fatal anaphylactic reactions in a murine model of breast cancer
por: Mall, Christine, et al.
Publicado: (2014)

Antibody-mediated phosphatidylserine blockade significantly enhances the efficacy of downstream immune checkpoint inhibition in K1735 mouse melanoma
por: Huang, Xianming, et al.
Publicado: (2014)

A cell separation checkpoint that enforces the proper order of late cytokinetic events
por: Brace, Jennifer L., et al.
Publicado: (2019)

Cancer Immunotherapy Beyond Checkpoint Blockade: JACC: CardioOncology State-of-the-Art Review
por: Welty, Nathan E., et al.
Publicado: (2022)

The mAbXcite platform modifies the tumor microenvironment when applied to an immune-oncology anti-CTLA4 antibody
por: Sansal-Castellano, Isabelle, et al.
Publicado: (2015)

Improved high-resolution pediatric vascular imaging with Gadofosveset-Enhanced 3d respiratory navigated IR GRE imaging compared to 3D bSSFP imaging
por: Tandon, Animesh, et al.
Publicado: (2015)

Background phase correction in congenital heart disease: does reliability vary based on underlying disease type?
por: Hashemi, Sassan, et al.
Publicado: (2016)

Targeting KIT on innate immune cells enhances the antitumor activity of checkpoint inhibitors in vivo
por: Gedrich, Richard, et al.
Publicado: (2015)

Computational discovery and experimental validation of novel drug targets in immuno-oncology
por: Levy, Ofer, et al.
Publicado: (2015)

Immune checkpoint inhibitors: Advances and impact in neuro-oncology
por: Fares, Jawad, et al.
Publicado: (2019)

Lessons From the Development of the Immune Checkpoint Inhibitors in Oncology
por: Jardim, Denis L., et al.
Publicado: (2018)

Antibody-mediated blockade of phosphatidylserine enhances the anti-tumor activity of targeted therapy and immune checkpoint inhibitors by affecting myeloid and lymphocyte populations in the tumor microenvironment
por: Yopp, Adam, et al.
Publicado: (2014)

Thinking security: stopping next year's hackers
por: Bellovin, Steven M
Publicado: (2016)

Adrenal masses in oncology patients
por: Reznek, Rodney H
Publicado: (2014)

Global challenges in oncologic imaging
por: Hricak, Hedvig
Publicado: (2014)

Acute presentation of oncologic disease
por: De Luca, SE, et al.
Publicado: (2014)

NUTRIC score in oncologic patients
por: Patrão, A, et al.
Publicado: (2015)

Combination of intravenously delivered cavatak (coxsackievirus A21) and immune-checkpoint blockade significantly reduces tumor growth and tumor rechallenge
por: Yuan, Min, et al.
Publicado: (2015)

Poxvirus immunotherapies in combination with immune checkpoint inhibitors synergize to eliminate tumors in a mouse tumor model
por: Foy, Susan P, et al.
Publicado: (2013)

Antibody Therapeutics in Oncology
por: Wold, Erik D, et al.
Publicado: (2016)

Application of next generation sequencing in oncology
por: Meyer, Brian
Publicado: (2014)

Incidental findings in the oncology patient: ovaries
por: Forstner, Rosemarie
Publicado: (2014)

Incidental lesion in oncology patients: kidneys
por: Sohaib, Aslam
Publicado: (2014)

Incidental findings in the oncology patient: liver
por: Schima, Wolfgang
Publicado: (2014)

Reporting oncoimaging in the appropriate oncology setting
por: De Luca, S, et al.
Publicado: (2015)

Identification of novel immune checkpoints as targets for cancer immunotherapy
por: Rotman, Galit, et al.
Publicado: (2013)

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_j6877qq9qkm4s4bf3plcom6rl1